Nilandron
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nilandron, covering 2014-10-29 to 2014-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 2]